Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of ursodeoxycholic acid in the treatment of indirect hyperbilirubinemia in neonates
IRCT20170719035178N2Phase 3Completed
- Sponsor
- Sabzevar University of Medical Sciences
- Start
- Oct 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ursodeoxycholic acid in indirect hyperbilirubinemia (IHB), sponsored by Sabzevar University of Medical Sciences. Started Oct 2018; status: completed.
02
Drugs
ursodeoxycholic acid
03
Conditions
indirect hyperbilirubinemia (IHB)
Beyond the preview
Go deeper on IRCT20170719035178N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170719035178N2.